UBS AG: Form 20-F for the period ended Dec 31, 2023
Filed with the SEC on Mar 28, 2024 and accepted by EDGAR at Mar 28, 2024, 11:10 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Income tax | 12 months2023-01-01 to 2023-12-31 | $1.21bn | ifrs-full:IncomeTaxExpenseContinuingOperations |
| Net income | 12 months2023-01-01 to 2023-12-31 | $3.31bn | ifrs-full:ProfitLoss |
| Operating cash flow | 12 months2023-01-01 to 2023-12-31 | −$28.20bn | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Cash and equivalents | At period end2023-12-31 | $190.47bn | ifrs-full:CashAndCashEquivalents |
| Total assets | At period end2023-12-31 | $1.16tn | ifrs-full:Assets |
| Total liabilities | At period end2023-12-31 | $1.10tn | ifrs-full:Liabilities |
| Shareholders' equity | At period end2023-12-31 | $55.23bn | ifrs-full:EquityAttributableToOwnersOfParent |
| Shares outstanding | At period end2023-12-31 | 3,858,408,466 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001114446-24-001605. Last ingested by Listed: Nov 6, 2026, 17:22 ET. Listed shows no prices and gives no investment advice.